Categories: Health

Texas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to use FDA-approved novel wireless system to treat cardiac arrhythmias

AUSTIN, Texas, July 21, 2025 /PRNewswire/ — Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center recently became the first in the nation to implant an FDA-approved novel leadless system that provides cardiac resynchronization therapy to patients with heart failure. Cardiac resynchronization therapy improves the timing of the heart’s contractions, helping to restore the normal rhythm of the heartbeat. The first procedure was recently performed by Robert Canby, M.D., cardiac electrophysiologist at TCAI.

- Advertisement -

“This technology marks a significant advancement in how we care for patients with heart rhythm disorders—particularly those who previously had few viable cardiac resynchronization therapy treatment options,” said Andrea Natale, M.D., F.H.R.S., F.A.C.C., F.E.S.C., cardiac electrophysiologist and executive medical director of TCAI. “At the Texas Cardiac Arrhythmia Institute, our commitment is to bring the most advanced, evidence-based therapies to patients worldwide, and as a result of Dr. Canby’s leadership, we successfully delivered on that promise.”

- Advertisement -

The system is the first-ever to stimulate the heart muscle electrically via a small, leadless device—about the size of a grain of rice—that is implanted inside tissue of the left ventricle, the heart’s primary pumping chamber. The device converts ultrasound energy into electrical pulses, restoring the heart’s normal rhythm and pumping efficiency.

- Advertisement -

Traditional cardiac resynchronization therapies involve leads—thin and soft insulated wires about the size of a spaghetti noodle. This left ventricular endocardial pacing device provides a direct approach, which enables more flexible placement and expands access to those who were previously considered untreatable.

- Advertisement -

TCAI is a state-of-the-art Electrophysiology Center that includes six labs equipped with advanced technology where a group of esteemed cardiac electrophysiologists—led by Dr. Natale, a world-renowned expert in the field—perform a high volume of the most complex electrophysiology procedures.

- Advertisement -

View original content:https://www.prnewswire.com/in/news-releases/texas-cardiac-arrhythmia-institute-at-st-davids-medical-center-first-in-us-to-use-fda-approved-novel-wireless-system-to-treat-cardiac-arrhythmias-302509006.html

- Advertisement -
PRNW Agency

Recent Posts

Satellogic Launches Very-High Resolution NextGen Satellite Platform for Sovereign, AI-First Earth Observation Missions

With an early customer commitment secured, Satellogic is advancing NextGen production to meet growing global…

9 minutes ago

EverQuote to Announce Third Quarter 2025 Financial Results on November 3, 2025

October 13, 2025 16:10 ET  | Source: EverQuote, Inc. CAMBRIDGE, Mass., Oct. 13, 2025 (GLOBE…

9 minutes ago

TEQUILA DON JULIO PARTNERS WITH MEXICO’S ACCLAIMED PANADERA ROSETTA TO BRING THE SPIRIT OF DA DE MUERTOS TO THE WORLD

Tequila Don Julio continues to celebrate and share Mexican culture globally with Panadería Don Julio pop-ups…

2 hours ago

Lamborghini returns to FIA Macau GT World Cup with twocar factory entry

Mortara and Engstler head up Absolute Corse entry on final full season outing for Huracán…

6 hours ago

The Kia EV5 Delivers Authentic SUV Practicality in an Accessible Electric Package

The Kia EV5 is designed to support active lifestyles by providing maximum versatility Model is…

6 hours ago

Jiuzi Holdings, Inc. (JZXN) Secures 100 Bitcoin via Private Placement, Signaling New Phase in Crypto Treasury Deployment

HANGZHOU, China, Oct. 13, 2025 /PRNewswire/ -- Jiuzi Holdings, Inc. (NASDAQ: JZXN, hereinafter referred to…

7 hours ago